These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28515919)

  • 1. Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Tsuchihashi K; Kusaba H; Yamada Y; Okumura Y; Shimokawa H; Komoda M; Uchino K; Yoshihiro T; Tsuruta N; Hanamura F; Inadomi K; Ito M; Sagara K; Nakano M; Nio K; Arita S; Ariyama H; Kohashi K; Tominaga R; Oda Y; Akashi K; Baba E
    Mol Clin Oncol; 2017 May; 6(5):665-668. PubMed ID: 28515919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS.
    Saeki H; Hoashi T; Tada Y; Ashida R; Kuwano Y; Le Pavoux A; Tsunemi Y; Shikada J; Torii H; Kawabata Y; Kikuchi K; Tamada Y; Matsumoto Y; Tamaki K
    J Dermatol Sci; 2003 Dec; 33(3):161-7. PubMed ID: 14643521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
    Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
    Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of metastatic fibrosarcomatous dermatofibrosarcoma protuberans with imatinib mesylate.
    Kambayashi Y; Kasahara Y; Ohuchi K; Amagai R; Hashimoto A; Asano Y; Fujimura T
    Dermatol Ther; 2022 Oct; 35(10):e15736. PubMed ID: 35898161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coamplification of 12q15 and 12p13 and homozygous CDKN2A/2B deletion: synergistic role of fibrosarcomatous transformation in dermatofibrosarcoma protuberans with a cryptic COL1A1-PDGFB fusion.
    Lu Y; Li T; Chen M; Peng H; Du T; Qiu Y; Zhang H
    Virchows Arch; 2022 Aug; 481(2):313-319. PubMed ID: 35171326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary metastasis of fibrosarcomatous variant of dermatofibrosarcoma protuberans: case report and review of literature].
    Otani S; Ishii H; Hashinaga K; Morinaga R; Umeki K; Kishi K; Shirai R; Tokimatsu I; Hiramatsu K; Kawahar K; Kadota J
    Nihon Kokyuki Gakkai Zasshi; 2008 Mar; 46(3):253-7. PubMed ID: 18409576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for distant metastasis of dermatofibrosarcoma protuberans.
    Hayakawa K; Matsumoto S; Ae K; Tanizawa T; Gokita T; Funauchi Y; Motoi N
    J Orthop Traumatol; 2016 Sep; 17(3):261-6. PubMed ID: 27289468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation.
    Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Osaki J; Ono T; Adachi Y; Tsuchiya R; Toda Y; Ogura K; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2023 Nov; 36(6):2187-2194. PubMed ID: 37490236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
    Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
    J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COL1A1-PDGFB fusion transcripts in fibrosarcomatous areas of six dermatofibrosarcomas protuberans.
    Wang J; Morimitsu Y; Okamoto S; Hisaoka M; Ishida T; Sheng W; Hashimoto H
    J Mol Diagn; 2000 Feb; 2(1):47-52. PubMed ID: 11272901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
    Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
    Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.
    Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD
    J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary metastases of fibrosarcomatous dermatofibrosarcoma protuberans respond to apatinib-based angiogenesis and chemotherapy: a case report.
    Chen H; Liu Y; Peng F; Huang J; Wen X; Ding Z; Zhang S; Zhang Y; Lu Y
    Ann Transl Med; 2019 Apr; 7(7):149. PubMed ID: 31157270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
    Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic Fibrosarcomatous Transformation of Dermatofibrosarcoma Protuberans With Lung Metastasis: A Case Report.
    Khan S; Yetiskul E; Niazi M; Zeb Khan MW; Pokima N; Khattar G; Terjanian T
    Cureus; 2024 May; 16(5):e59742. PubMed ID: 38841035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatofibrosarcoma protuberans: A retrospective study of clinicopathologic features and related Akt/mTOR, STAT3, ERK, cyclin D1, and PD-L1 expression.
    Park S; Cho S; Kim M; Park JU; Jeong EC; Choi E; Park JH; Lee C; Chang MS
    J Am Acad Dermatol; 2018 Nov; 79(5):843-852. PubMed ID: 29792909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of PDGFRβ-Akt-mTOR pathway signaling in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
    Hiraki-Hotokebuchi Y; Yamada Y; Kohashi K; Yamamoto H; Endo M; Setsu N; Yuki K; Ito T; Iwamoto Y; Furue M; Oda Y
    Hum Pathol; 2017 Sep; 67():60-68. PubMed ID: 28711648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib.
    Stacchiotti S; Pedeutour F; Negri T; Conca E; Marrari A; Palassini E; Collini P; Keslair F; Morosi C; Gronchi A; Pilotti S; Casali PG
    Int J Cancer; 2011 Oct; 129(7):1761-72. PubMed ID: 21128251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Risk Factors for Fibrosarcomatous Transformation in Dermatofibrosarcoma Protuberans.
    Mallett KE; Almubarak S; Claxton RM; Ferguson PC; Griffin AM; Rose PS; Wunder JS; Tsoi K; Houdek MT
    Anticancer Res; 2022 Jan; 42(1):105-108. PubMed ID: 34969715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosarcomatous dermatofibrosarcoma protuberans from scar following trauma.
    Lee SW; Zaesim A; Jackson A; Borkat M
    Autops Case Rep; 2018; 8(4):e2018039. PubMed ID: 30775318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.